Filing Flows

Filing Flows › Phathom Pharmaceuticals (PHAT) › Next earnings date

Phathom Pharmaceuticals (PHAT) earnings: beat the estimate

Phathom Pharmaceuticals (PHAT) reported on Oct 29, 2026 and beat the EPS estimate: $0.04 against $0.03 (+39.9%). Revenue was $84.7M for Q3 2026, +71% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+39.9% vs estimate
Beat rate100%

The last report

Phathom Pharmaceuticals reported revenue of $84.7M for the third quarter 2026 (+71% Y/Y), net loss $13.9M. How it makes money → · Every quarter →

Phathom Pharmaceuticals: EPS against the estimate, last 5 reportsPhathom Pharmaceuticals: EPS against the estimate, last 5 reportsEstimateReported−$0.41−$0.15Oct 25−$0.19−$0.08Feb 26−$0.19−$0.18Apr 26−$0.10$0.00Jul 26$0.03$0.04Oct 26
Latest (Oct 26): Estimate $0.03, Reported $0.04.

Phathom Pharmaceuticals' latest quarter

Phathom Pharmaceuticals, Q3 2026: revenue $84.7M (+71% year over year), operating margin -0.1%, net loss $13.9M, operating cash flow $1.8M. The chart follows the revenue to costs, profit and cash.

Questions

Did Phathom Pharmaceuticals beat earnings?

Phathom Pharmaceuticals (PHAT) reported on Oct 29, 2026 and beat the EPS estimate: $0.04 against $0.03 (+39.9%).

When does PHAT report earnings?

The next date is not set yet.

Does Phathom Pharmaceuticals usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.